Globe Newswire Company announcement No. 45 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, September 12, 2024 Zealand Pharma A/S...\n more…
Globe Newswire Company announcement No. 44 / 2024 Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist...\n more…
Globe Newswire Company announcement No. 43 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons...\n more…
Globe Newswire Company announcement No. 42 / 2024 Total number of shares and voting rights in Zealand Pharma on August 30, 2024 Copenhagen, Denmark, August 30, 2024 Zealand Pharma A/S ( Zealand...\n more…
Globe Newswire Company announcement No. 41 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, August 22, 2024 Zealand Pharma A/S...\n more…
Globe Newswire Company announcement No. 40 / 2024 Zealand Pharma major shareholder announcement: Bank of America Corporation Copenhagen, Denmark, 16 August 2024 Zealand Pharma A/S ( Zealand ) (Nasdaq...\n more…